Going over the other answer choices:
Blocking ATP sensitive potassium channels in the pancreatic beta cells to increase insulin secretion would be drugs like Sulfonylureas or Meglitinides for example like Glyburide.
Increasing endogenous GLP1 or GIP levels are drugs like Sitagliptan and Saxagliptan. They have GLP in them
Increasing peripheral glucose uptake would be the biguanides like metformin.
Stimulating transcription regulator PPAR-gamma decreases insulin resistance and is the MOA of thiazolidenediones like Pioglitazone.
why not C?. It´s not supose that it improve the efectivity of insulin?
Pioglitazone is an oral thiazolidinedione that is used for the treatment of type 2 diabetes mellitus. it binds to peroxisome proliferator-activated receptors (PPARs): act as transcription factors to regulate metabolism and promote insulin sensitivity.
submitted by sgarzon15(11)
Thank you glitter zone of sketchy pharm. I shall never forget you